Effects of ginger on cardiovascular risk factors in peritoneal dialysis patients
Phase 2
- Conditions
- cardiovascular risk factors in peritoneal dialysis.
- Registration Number
- IRCT201312062716N2
- Lead Sponsor
- ational Nutrition and Food Technology Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Inclusion criterion: Continuous Ambulatory Peritoneal Dialysis for 6 months or more.
Exclusion criteria: infections; inflammatory diseases; thyroid disorders; gastrointestinal diseases; receiving anti-inflammatory drugs, thyroxine, warfarin, vitamins B6, E, C, and Omega-3 fatty acids supplement.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde. Timepoint: Baseline and Week 10. Method of measurement: enzyme-linked immunosorbent assay (ELISA).
- Secondary Outcome Measures
Name Time Method Serum pentosidine, carboxymethyl lysine, hs-CRP, IL-6, sICAM-1, sVCAM-1, TG, TC, LDL-C, HDL-C, apo AI, apo B100, Lp(a). Timepoint: Baseline and Week10. Method of measurement: ELISA & Enzymatic method.